Drug combo ups progression-free survival for metastatic prostate cancer
by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord
Updated on: January 30,2024
18

Drug combo ups progression-free survival for metastatic prostate cancer
by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord
Updated on:January 30,2024
18
